Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries

The New York Times – Business:

Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.

Stephanie Nolen
Author: Stephanie Nolen

This post first appeared in The New York Times – Business. Read the original article.

Written by

Stephanie Nolen

in

Brazil, Cystic Fibrosis, Drugs (Pharmaceuticals), Generic Brands and Products, India, Inventions and Patents, South Africa, Third World and Developing Countries, Turkey, Ukraine, Vertex Pharmaceuticals Inc
←Fifteen Percent Pledge Gala Calls on the Fashion Industry for Change
Young, Gifted And Black: Meet The Next Generation Of Black Hollywood→

More posts

  • Nigel Farage tells BBC he ‘wasn’t listening’ during foreign donor talks filmed undercover

  • Iran’s Attacks Keep the Strait of Hormuz in a Lethal Stalemate

  • QUIZ: Ugh, I’ll do it later. How much do you know about procrastination?

  • How a Blacklisted Chinese Tech Giant Kept Buying America’s Best A.I. Chips

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube